CPC Scientific Overview
- Founded
-
2001

- Status
-
Acquired/Merged
- Employees
-
201

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$323M
CPC Scientific General Information
Description
Provider of contract development and manufacturing services for synthetic peptide production. The company offers tides, peptide synthesis reagents, amino acids, Fret and TR-FRET substrates to pharmaceutical, biotechnology companies and universities
Contact Information
Website
www.cpcscientific.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
BPO/Outsource Services
Parent Company
Primary Office
- 160 E Tasman Drive
- Suite 200
- San Jose, CA 95134
- United States
+1 (408) 000-0000
CPC Scientific Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Merger/Acquisition | 01-Jan-2015 | $323M | 00000 | Completed | Generating Revenue | |
1. Early Stage VC (Series A) | 07-Nov-2012 | Completed | Generating Revenue |
CPC Scientific Executive Team (12)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Shawn Lee Ph.D | Founder & Chief Executive Officer | ||
Theresa Cheng | President | ||
Irvine Skeoch | Chief Operating Officer | ||
Xiaohe Tong Ph.D | Chief Technical Officer | ||
May Feng | Vice President & Board Secretary |
CPC Scientific Signals
CPC Scientific Former Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Lilly Asia Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |